Literature DB >> 29443424

CCL23 is a promising biomarker of injury in patients with ischaemic stroke.

A Bonaventura1, F Montecucco1,2,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29443424     DOI： 10.1111/joim.12742

Source DB:  PubMed          Journal:  J Intern Med        ISSN： 0954-6820            Impact factor:   8.989


× No keyword cloud information.
  2 in total

1.  Inhibitory effect of CC chemokine ligand 23 (CCL23)/ transcription factor activating enhancer binding protein 4 (TFAP4) on cell proliferation, invasion and angiogenesis in hepatocellular carcinoma.

Authors:  Weiwei Wang; Jianjun Wu; Xulei Dai; Kun Cheng
Journal:  Bioengineered       Date:  2022-01       Impact factor: 3.269

2.  The Relationship Between Chemokine and Chemokine Receptor Genes Polymorphisms and Chronic Obstructive Pulmonary Disease Susceptibility in Tatar Population from Russia: A Case Control Study.

Authors:  Gulnaz F Korytina; Yulia G Aznabaeva; Leysan Z Akhmadishina; Olga V Kochetova; Timur R Nasibullin; Naufal Sh Zagidullin; Shamil Z Zagidullin; Tatyana V Viktorova
Journal:  Biochem Genet       Date:  2021-06-06       Impact factor: 1.890
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.